{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:52:59Z","timestamp":1790855579627,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>C-reactive protein (CRP) is one of the biomarkers for the diagnosis and assessment of disease activity in rheumatoid arthritis (RA). CRP is not only the by-product of inflammatory response, but also plays proinflammatory and prothrombotic roles. The aim of this study was to determine the role of CRP on bone destruction in RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CRP levels in RA synovial fluid (SF) and serum were measured using the immunoturbidimetric method. The expression of CRP in RA synovium was assessed using immunohistochemical staining. CD14+ monocytes from peripheral blood were cultured with CRP, and receptor activator of nuclear factor-\u03baB ligand (RANKL) expression and osteoclast differentiation were evaluated using real-time PCR, counting tartrate resistant acid phosphatase (TRAP)-positive multinucleated cells and assessing bone resorbing function. CRP-induced osteoclast differentiation was also examined after inhibition of Fc\u03b3 receptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a significant correlation between CRP levels in serum and SF in RA patients. The SF CRP level was correlated with interleukin (IL)-6 levels, but not with RANKL levels. Immunohistochemical staining revealed that compared with the osteoarthritis synovium, CRP was more abundantly expressed in the lining and sublining areas of the RA synovium. CRP stimulated RANKL production in monocytes and it induced osteoclast differentiation from monocytes and bone resorption in the absence of RANKL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CRP could play an important role in the bony destructive process in RA through the induction of RANKL expression and direct differentiation of osteoclast precursors into mature osteoclasts. In the treatment of RA, lowering CRP levels is a significant parameter not only for improving disease activity but also for preventing bone destruction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-015-0563-z","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T13:42:14Z","timestamp":1425390134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis"],"prefix":"10.1186","volume":"17","author":[{"given":"Kyoung-Woon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Won","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"563_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012;64:640\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"563_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137.","journal-title":"Ann Rheum Dis"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/acr.20621","volume":"63","author":"JK Anderson","year":"2011","unstructured":"Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken). 2011;63:S14\u201336.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"563_CR4","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"563_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3904\/kjim.2012.27.4.378","volume":"27","author":"YO Jung","year":"2012","unstructured":"Jung YO, Kim HA. Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis. Korean J Intern Med. 2012;27:378\u201387.","journal-title":"Korean J Intern Med"},{"key":"563_CR6","first-page":"224","volume":"9","author":"RK Mallya","year":"1982","unstructured":"Mallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol. 1982;9:224\u20138.","journal-title":"J Rheumatol"},{"key":"563_CR7","first-page":"1477","volume":"24","author":"F Wolfe","year":"1997","unstructured":"Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol. 1997;24:1477\u201385.","journal-title":"J Rheumatol"},{"key":"563_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1440-1827.2002.01389.x","volume":"52","author":"H Matsuno","year":"2002","unstructured":"Matsuno H, Yudoh K, Nakazawa F, Koizumi F. Relationship between histological findings and clinical findings in rheumatoid arthritis. Pathol Int. 2002;52:527\u201333.","journal-title":"Pathol Int"},{"key":"563_CR9","first-page":"425","volume":"21","author":"MA van Leeuwen","year":"1994","unstructured":"van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol. 1994;21:425\u20139.","journal-title":"J Rheumatol"},{"key":"563_CR10","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","volume":"43","author":"MJ Plant","year":"2000","unstructured":"Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:1473\u20137.","journal-title":"Arthritis Rheum"},{"key":"563_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nrrheum.2011.37","volume":"7","author":"B Rhodes","year":"2011","unstructured":"Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011;7:282\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"563_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/ard.60.10.924","volume":"60","author":"LM Jansen","year":"2001","unstructured":"Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis. 2001;60:924\u20137.","journal-title":"Ann Rheum Dis"},{"key":"563_CR13","first-page":"9","volume":"24","author":"J Devlin","year":"1997","unstructured":"Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, et al. The acute phase and function in early rheumatoid arthritis, C-reactive protein levels correlate with functional outcome. J Rheumatol. 1997;24:9\u201313.","journal-title":"J Rheumatol"},{"key":"563_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1107\/S0907444996008311","volume":"52","author":"AK Shrive","year":"1996","unstructured":"Shrive AK, Holden D, Myles DA, Greenhough TJ. Structure solution of C-reactive proteins: molecular replacement with a twist. Acta Crystallogr D Biol Crystallogr. 1996;52:1049\u201357.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"563_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","volume":"15","author":"H Baumann","year":"1994","unstructured":"Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;15:74\u201380.","journal-title":"Immunol Today"},{"key":"563_CR16","doi-asserted-by":"publisher","first-page":"9503","DOI":"10.1074\/jbc.271.16.9503","volume":"271","author":"D Zhang","year":"1996","unstructured":"Zhang D, Sun M, Samols D, Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem. 1996;271:9503\u20139.","journal-title":"J Biol Chem"},{"key":"563_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1084\/jem.164.1.321","volume":"164","author":"AE Kuta","year":"1986","unstructured":"Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med. 1986;164:321\u20136.","journal-title":"J Exp Med"},{"key":"563_CR18","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","volume":"108","author":"P Calabro","year":"2003","unstructured":"Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108:1930\u20132.","journal-title":"Circulation"},{"key":"563_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jacc.2005.06.017","volume":"46","author":"P Calabro","year":"2005","unstructured":"Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005;46:1112\u20133.","journal-title":"J Am Coll Cardiol"},{"key":"563_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1084\/jem.142.3.709","volume":"142","author":"J Siegel","year":"1975","unstructured":"Siegel J, Osmand AP, Wilson MF, Gewurz H. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J Exp Med. 1975;142:709\u201321.","journal-title":"J Exp Med"},{"key":"563_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","volume":"42","author":"C Mold","year":"1999","unstructured":"Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology. 1999;42:23\u201330.","journal-title":"Immunopharmacology"},{"key":"563_CR22","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165\u20138.","journal-title":"Circulation"},{"key":"563_CR23","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V Pasceri","year":"2001","unstructured":"Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001;103:2531\u20134.","journal-title":"Circulation"},{"key":"563_CR24","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","volume":"106","author":"SK Venugopal","year":"2002","unstructured":"Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439\u201341.","journal-title":"Circulation"},{"key":"563_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nature07468","volume":"456","author":"J Lu","year":"2008","unstructured":"Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature. 2008;456:989\u201392.","journal-title":"Nature"},{"key":"563_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"563_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/rheumatology\/kes259","volume":"52","author":"J Kikuta","year":"2013","unstructured":"Kikuta J, Ishii M. Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. Rheumatology. 2013;52:226\u201334.","journal-title":"Rheumatology"},{"key":"563_CR28","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/eurheartj\/ehq238","volume":"31","author":"RJ Bisoendial","year":"2010","unstructured":"Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087\u201391.","journal-title":"Eur Heart J"},{"key":"563_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1258\/ebm.2012.011373","volume":"237","author":"X Wang","year":"2012","unstructured":"Wang X, Liu X, Kishimoto C, Yuan Z. The role of Fcgamma receptors in atherosclerosis. Exp Biol Med. 2012;237:609\u201316.","journal-title":"Exp Biol Med"},{"key":"563_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1084\/jem.190.4.585","volume":"190","author":"D Bharadwaj","year":"1999","unstructured":"Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999;190:585\u201390.","journal-title":"J Exp Med"},{"key":"563_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/01.ATV.0000104014.24367.16","volume":"24","author":"TN Williams","year":"2004","unstructured":"Williams TN, Zhang CX, Game BA, He L, Huang Y. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler Thromb Vasc Biol. 2004;24:61\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"563_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2007.03.003","volume":"196","author":"A Nabata","year":"2008","unstructured":"Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque. Atherosclerosis. 2008;196:129\u201335.","journal-title":"Atherosclerosis"},{"key":"563_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1189\/jlb.0808458","volume":"85","author":"S Devaraj","year":"2009","unstructured":"Devaraj S, Yun JM, Duncan-Staley C, Jialal I. C-reactive protein induces M-CSF release and macrophage proliferation. J Leukoc Biol. 2009;85:262\u20137.","journal-title":"J Leukoc Biol"},{"key":"563_CR34","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1161\/01.CIR.0000131160.94926.6E","volume":"109","author":"KH Han","year":"2004","unstructured":"Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ, et al. C-reactive protein promotes monocyte chemoattractant protein-1\u2013mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation. 2004;109:2566\u201371.","journal-title":"Circulation"},{"key":"563_CR35","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1002\/art.22253","volume":"54","author":"PL van Lent","year":"2006","unstructured":"van Lent PL, Grevers L, Lubberts E, de Vries TJ, Nabbe KC, Verbeek S, et al. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. Arthritis Rheum. 2006;54:3868\u201377.","journal-title":"Arthritis Rheum"},{"key":"563_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/annrheumdis-2012-201568","volume":"72","author":"LC Grevers","year":"2013","unstructured":"Grevers LC, de Vries TJ, Everts V, Verbeek JS, van den Berg WB, van Lent PL. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcgamma receptors on myeloid precursor cells. Ann Rheum Dis. 2013;72:278\u201385.","journal-title":"Ann Rheum Dis"},{"key":"563_CR37","doi-asserted-by":"publisher","first-page":"10729","DOI":"10.1073\/pnas.1301001110","volume":"110","author":"M Seeling","year":"2013","unstructured":"Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, et al. Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A. 2013;110:10729\u201334.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0563-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0563-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0563-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0563-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:31:51Z","timestamp":1728909111000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0563-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0563-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725392659.793507907","asserted-by":"object"}]},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]},"assertion":[{"value":"17 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}